Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression

Molecular and Cellular Neuroscience

Volumn 24, Issue 3, 2003, Pages 696-708

  Haegele, Lorenz ^a   Ingold, Barbara ^a   Naumann, Heike ^b   Tabatabai, Ghazaleh ^a   Ledermann, Birgit ^c   Brandner, Sebastian ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CYCLINE; MYC PROTEIN; NOGGIN; PROTEIN INHIBITOR; WNT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN GRAFT; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FEMALE; INHIBITION KINETICS; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0345167829     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00232-X     Document Type: Article

References (56)

1. Bain G., Ray W.J., Yao M., Gottlieb D.I. Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem. Biophys. Res. Commun. 223:1996;691-694.
2. Bain G., Kitchens D., Yao M., Huettner J.E., Gottlieb D.I. Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 168:1995;342-357.
3. Baker J.C., Beddington R.S., Harland R.M. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev. 13:1999;3149-3159.
4. Barth A.I., Stewart D.B., Nelson W.J. T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin. Proc. Natl. Acad. Sci. USA. 96:1999;4947-4952.
5. Barth A.I., Pollack A.L., Altschuler Y., Mostov K.E., Nelson W.J. NH2-terminal deletion of beta-catenin results in stable colocalization of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J. Cell Biol. 136:1997;693-706.
6. Benninger Y., Marino S., Hardegger R., Weissmann C., Aguzzi A., Brandner S. Differentiation and histological analysis of embryonic stem cell-derived neural transplants in mice. Brain Pathol. 10:2000;330-341.
7. Bhat R.V., Baraban J.M., Johnson R.C., Eipper B.A., Mains R.E. High levels of expression of the tumor suppressor gene APC during development of the rat central nervous system. J. Neurosci. 14:1994;3059-3071.
8. Bhat R.V., Axt K.J., Fosnaugh J.S., Smith K.J., Johnson K.A., Hill D.E., Kinzler K.W., Baraban J.M. Expression of the APC tumor suppressor protein in oligodendroglia. Glia. 17:1996;169-174.
9. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 128:2001;1253-1264.
10. Chenn A., Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science. 297:2002;365-369.
11. Clevers H., van de Wetering M. TCF/LEF factor earn their wings. Trends Genet. 13:1997;485-489.
12. Dickinson M.E., Krumlauf R., McMahon A.P. Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system. Development. 120:1994;1453-1471.
13. Dinsmore J., Ratliff J., Deacon T., Pakzaban P., Jacoby D., Galpern W., Isacson O. Embryonic stem cells differentiated in vitro as a novel source of cells for transplantation. Cell Transplant. 5:1996;131-143.
14. Dobashi Y., Katayama K., Kawai M., Akiyama T., Kameya T. APC protein is required for initiation of neuronal differentiation in rat pheochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 279:2000;685-691.
15. Dunn K.J., Williams B.O., Li Y., Pavan W.J. Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc. Natl. Acad. Sci. USA. 97:2000;10050-10055.
16. Fagotto F., Gluck U., Gumbiner B.M. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr. Biol. 8:1998;181-190.
17. Finley M.F., Devata S., Huettner J.E. BMP-4 inhibits neural differentiation of murine embryonic stem cells. J. Neurobiol. 40:1999;271-287.
18. Fodde R., Smits R., Clevers H. APC, Signal transduction and genetic instability in colorectal cancer. Nature Reviews Cancer. 1:2001;55-67.
19. Fodde R., Edelmann W., Yang K., van Leeuwen C., Carlson C., Renault B., Breukel C., Alt E., Lipkin M., Khan P.M., et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA. 91:1994;8969-8973.
20. Hasegawa S., Sato T., Akazawa H., Okada H., Maeno A., Ito M., Sugitani Y., Shibata H., Miyazaki Ji J., Katsuki M., Yamauchi Y., Yamamura Ki K., Katamine S., Noda T. Apoptosis in neural crest cells by functional loss of APC tumor suppressor gene. Proc. Natl. Acad. Sci. USA. 99:2002;297-302.
21. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
22. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell. Biol. 2:2000;653-660.
23. Huang H., Fujii H., Sankila A., Mahler-Araujo B.M., Matsuda M., Cathomas G., Ohgaki H. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 155:1999;1795-1801.
24. Huang H., Mahler-Araujo B.M., Sankila A., Chimelli L., Yonekawa Y., Kleihues P., Ohgaki H. APC mutations in sporadic medulloblastomas. Am. J. Pathol. 156:2000;433-437.
25. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22:2002;1172-1183.
26. Kielman M.F., Rindapaa M., Gaspar C., Van Poppel N., Breukel C., Van Leeuwen S., Taketo M.M., Roberts S., Smits R., Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat. Genet. 32:2002;594-605.
27. Ledermann B., Burki K. Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell. Res. 197:1991;254-258.
28. Loureiro J.J., Akong K., Cayirlioglu P., Baltus A.E., DiAntonio A., Peifer M. Activated armadillo/beta-catenin does not play a general role in cell migration and process extension in Drosophila. Dev. Biol. 235:2001;33-44.
29. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22:2002;1184-1193.
30. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development. 129:2002;2087-2098.
31. Mehler M.F., Mabie P.C., Zhu G., Gokhan S., Kessler J.A. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev. Neurosci. 22:2000;74-85.
32. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 86:1996;391-399.
33. Moser A.R., Mattes E.M., Dove W.F., Lindstrom M.J., Haag J.D., Gould M.N. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl. Acad. Sci. USA. 90:1993;8977-8981.
34. Moser A.R., Shoemaker A.R., Connelly C.S., Clipson L., Gould K.A., Luongo C., Dove W.F., Siggers P.H., Gardner R.L. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dyn. 203:1995;422-433.
35. Munemitsu S., Albert I., Rubinfeld B., Polakis P. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol. 16:1996;4088-4094.
36. Munoz-Sanjuan I., Brivanlou A.H. Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 3:2002;271-280.
37. Nathke I.S., Adams C.L., Polakis P., Sellin J.H., Nelson W.J. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol. 134:1996;165-179.
38. Rosin-Arbesfeld R., Townsley F., Bienz M. The APC tumour suppressor has a nuclear export function. Nature. 406:2000;1009-1012.
39. Rosin-Arbesfeld R., Ihrke G., Bienz M. Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells. EMBO J. 20:2001;5929-5939.
40. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science. 272:1996;1023-1026.
41. Sasai H., Masaki M., Wakitani K. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis. 21:2000;953-958.
42. Sasai Y. Regulation of neural determination by evolutionarily conserved signals anti-BMP factors and what next? Curr. Opin. Neurobiol. 11:2001;22-26.
43. Shou J., Rim P.C., Calof A.L. BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor. Nat. Neurosci. 2:1999;339-345.
44. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
45. Smits R., van der Houven van Oordt W., Luz A., Zurcher C., Jagmohan-Changur S., Breukel C., Khan P.M., Fodde R. Apc1638N a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts . Gastroenterology. 114:1998;275-283.
46. Streit A., Lee K.J., Woo I., Roberts C., Jessell T.M., Stern C.D. Chordin regulates primitive streak development and the stability of induced neural cells, but is not sufficient for neural induction in the chick embryo. Development. 125:1998;507-519.
47. Strubing C., Ahnert-Hilger G., Shan J., Wiedenmann B., Hescheler J., Wobus A.M. Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech. Dev. 53:1995;275-287.
48. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
49. Wessely O., Agius E., Oelgeschlager M., Pera E.M., De Robertis E.M. Neural induction in the absence of mesoderm beta-catenin-dependent expression of secreted BMP antagonists at the blastula stage in Xenopus . Dev. Biol. 234:2001;161-173.
50. Wilson S.I., Rydstrom A., Trimborn T., Willert K., Nusse R., Jessell T.M., Edlund T. The status of Wnt signalling regulates neural and epidermal fates in the chick embryo. Nature. 411:2001;325-330.
51. Wong M.H., Huelsken J., Birchmeier W., Gordon J.I. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of lieberkuhn is perturbed by stimulation of lef-1/beta-catenin signaling. J. Biol. Chem. 277:2002;15843-15850.
52. Wood H.B., Episkopou V. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech. Dev. 86:1999;197-201.
53. Ying Q.L., Stavridis M., Griffiths D., Li M., Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 21:2003;183-186.
54. Zindy F., Soares H., Herzog K.H., Morgan J., Sherr C.J., Roussel M.F. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ. 8:1997;1139-1150.
55. Zumbrunn J., Kinoshita K., Hyman A.A., Nathke I.S. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr. Biol. 11:2001;44-49.
56. Zurawel R.H., Chiappa S.A., Allen C., Raffel C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res. 58:1998;896-899.